10/03/2017 - 2:13pm

The drug is indicated to treat infections caused by various micro-organisms and as an adjunctive therapy for severe acne.

10/03/2017 - 1:33pm

In a post on the Food and Drug Administration’s blog, commissioner Dr. Scott Gottlieb noted that in many instances complex drugs — which include drugs with complex active ingredients and complex drug-device combination products — do not have generic competitors for various reasons.

10/02/2017 - 1:56pm

The drug had U.S. sales of approximately $1.7 billion for the 12 months ended July 31, according to QunitilesIMS data. 

09/29/2017 - 12:34pm

Humira manufacturer AbbVie and Amgen, maker of Humira biosimilar Amjevita (sometimes spelled Amgevita), have reached a settlement that will allow the biosimilar to launch — but not for several years. 

09/29/2017 - 12:24pm

The drug had U.S. sales of approximately $350 million for the 12 months ending July 2017, according to QuintilesIMS data. 

09/27/2017 - 3:33pm
09/26/2017 - 12:58pm

The drug marks another approval for Teva’s generic injectable business, which the company has been focused on growing. 

09/26/2017 - 12:50pm

The product is indicated to relieve various corticosteroid-responsive dermatoses in patients ages 18 years and older.

09/21/2017 - 12:54pm

The drug is an opioid indicated to manage moderate to severe pain in patients requiring continuous around-the-clock pain opioid analgesia for an extended period of time.